Human Genome Epidemiology Literature Finder
Records 1 - 20 (of 20 Records) |
Query Trace: PLK1[original query] |
---|
The RNA helicase/transcriptional co-regulator, p68 (DDX5), stimulates expression of oncogenic protein kinase, Polo-like kinase-1 (PLK1), and is associated with elevated PLK1 levels in human breast cancers. Cell cycle (Georgetown, Tex.) 2014 13 (9): 1413-23. Iyer R Sumanth, Nicol Samantha M, Quinlan Philip R, Thompson Alastair M, Meek David W, Fuller-Pace Frances |
Study of apoptosis-related interactions in colorectal cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2016 Sep . Arora Himanshu, Qureshi Rehana, Rizvi M A, Shrivastava Sharad, Parihar Mordhwaj |
Single nucleotide polymorphisms rs911160 in AURKA and rs2289590 in AURKB mitotic checkpoint genes contribute to gastric cancer susceptibility. Environmental and molecular mutagenesis 2017 Aug . Mesic Aner, Markocic Ela, Rogar Marija, Juvan Robert, Hudler Petra, Komel Radov |
Polo-like kinase 1 (PLK1)-dependent phosphorylation of methylenetetrahydrofolate reductase (MTHFR) regulates replication via histone methylation. Cell cycle (Georgetown, Tex.) 2017 Aug 0. Li Xueyan, Nai Shanshan, Ding Yuehe, Geng Qizhi, Zhu Bingtao, Yu Kai, Zhu Wei-Guo, Dong Meng-Qiu, Su Xiao-Dong, Xu Xingzhi, Li Ji |
Comprehensive Biomarker Analyses in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Prospectively Treated with the Polo-Like Kinase 1 Inhibitor BI2536. Oncology research and treatment 2017 40 (7-8): 435-439. Breitenbuecher Frank, von Pawel Joachim, Sebastian Martin, Kortsik Cornelius, Ting Saskia, Kasper Stefan, Wohlschläger Jeremias, Worm Karl, Morresi-Hauf Alicia, Schad Arno, Westerwick Daniela, Wehler Beatrice, Werner Martin, Munzert Gerd, Gaschler-Markefski Birgit, Schmid Kurt W, Schuler Mart |
Exploration of gene expression profiles and immune microenvironment between high and low tumor mutation burden groups in prostate cancer. International immunopharmacology 2020 6 86 106709. Luo Cheng, Chen Junxing, Chen Ling |
Genetic variations in AURORA cell cycle kinases are associated with glioblastoma multiforme. Scientific reports 2021 9 11 (1): 17444. Mesic Aner, Rogar Marija, Hudler Petra, Bilalovic Nurija, Eminovic Izet, Komel Radov |
Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics. BMC cancer 2021 5 21 (1): 619. Chen Cheng, Tang Yang, Qu Wen-Dong, Han Xu, Zuo Jie-Bin, Cai Qing-Yong, Xu Gang, Song Yong-Xiang, Ke Xi-Xi |
Comprehensive analysis of tumour mutational burden and its clinical significance in prostate cancer. BMC urology 2021 2 21 (1): 29. Wang Lijuan, Pan Shucheng, Zhu Binbin, Yu Zhenliang, Wang W |
Toll-like receptor 3 is a potential prognosis marker and associated with immune infiltration in stomach adenocarcinoma. Cancer biomarkers : section A of Disease markers 2021 10 34 (1): 77-93. Huang Zhihao, He Aoxiao, Wang Jiakun, Lu Hongcheng, Xu Xiaoyun, Zhang Rongguiyi, Liao Wenjun, Feng Qian, Wu Linqu |
Exploring the dysregulated mRNAs-miRNAs-lncRNAs interactions associated to idiopathic non-obstructive azoospermia. Journal of biomolecular structure & dynamics 2021 Jan 1-9. Sabetian Soudabeh, Zarei Mahboubeh, Jahromi Bahia Namavar, Morowvat Mohammad Hossein, Tabei Seyed Mohammad Bagher, Cava Claud |
BRCA1 transports the DNA damage signal for CDDP-induced centrosome amplification through the centrosomal Aurora A. Cancer science 2022 9 113 (12): 4230-4243. Qi Huicheng, Kikuchi Megumi, Yoshino Yuki, Fang Zhenzhou, Ohashi Kazune, Gotoh Takato, Ideta Ryo, Ui Ayako, Endo Shino, Otsuka Kei, Shindo Norihisa, Gonda Kohsuke, Ishioka Chikashi, Miki Yoshio, Iwabuchi Tokuro, Chiba Natsu |
Necroptosis-Related Prognostic Signature and Nomogram Model for Predicting the Overall Survival of Patients with Lung Cancer. Genetics research 2022 2022 4908608. Xuan Yunpeng, Jin Xiangfeng, Wang Mingzhao, Wang Zizo |
Plk1 regulates mutant IDH1 enzyme activity and mutant IDH2 ubiquitination in mitosis. Cellular signalling 2022 2 92 110279. Saikiran Reddy M, Bhattacharjee Debanjan, Jain Nisha |
A pan-cancer analysis of the oncogenic role of ERCC6L. BMC cancer 2022 12 22 (1): 1347. Lu Zhimin, Fei Lihong, Hou Guox |
In vivo efficacy assessment of the CDK4/6 inhibitor palbociclib and the PLK1 inhibitor volasertib in human chordoma xenografts. Frontiers in oncology 2022 12 12 960720. Passeri Thibault, Dahmani Ahmed, Masliah-Planchon Julien, El Botty Rania, Courtois Laura, Vacher Sophie, Marangoni Elisabetta, Nemati Fariba, Roman-Roman Sergio, Adle-Biassette Homa, Mammar Hamid, Froelich Sébastien, Bièche Ivan, Decaudin Didi |
Predicting the prognosis of hepatocellular carcinoma based on the interaction between pyroptosis, apoptosis, and necroptosis. Clinical and experimental medicine 2022 Oct . Qian Fang, Kong Wei, Wang Shuaiqun, Wei K |
Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis. International journal of molecular sciences 2022 10 23 (19): . Horjus Julia, van Mourik-Banda Tineke, Heerings Marco A P, Hakobjan Marina, De Witte Ward, Heersema Dorothea J, Jansen Anne J, Strijbis Eva M M, de Jong Brigit A, Slettenaar Astrid E J, Zeinstra Esther M P E, Hoogervorst Erwin L J, Franke Barbara, Kruijer Wiebe, Jongen Peter J, Visser Leo J, Poelmans Gee |
Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia. Annals of hematology 2023 9 . Peter J P Croucher, Maya Ridinger, Pamela S Becker, Tara L Lin, Sandra L Silberman, Eunice S Wang, Amer M Zeid |
Development and Validation of a Prognosis-Prediction Signature for Patients with Lung Adenocarcinoma Based on 11 Telomere-Related Genes. Frontiers in bioscience (Landmark edition) 2023 11 28 (10): 254. Jia Liu, Sha Sha, Jian Wang, Xiaowei Gu, Menghua Du, Xu |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: